The management of diabetes in patients with advanced cancer

Journal of Pain and Symptom Management

Volumn 13, Issue 6, 1997, Pages 339-346

  Poulson, Jane ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Toronto Grace Health Centre   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cancer; Diabetes mellitus; Dietary restrictions; Glucocorticoids; Hyperglycemia; Hypoglycemia; Insulin; Terminal illness

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; DIURETIC AGENT; FUROSEMIDE; GLIBENCLAMIDE; GLUCAGON; ISOPHANE INSULIN;

ADULT; ADVANCED CANCER; ANOREXIA; ARTICLE; CALORIC INTAKE; CANCER PAIN; CASE REPORT; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG CARCINOMA; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; QUALITY OF LIFE; SUPERIOR CAVA VEIN SYNDROME; TERMINAL DISEASE; VOMITING;

BLOOD GLUCOSE; CARCINOMA, SQUAMOUS CELL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; GLYBURIDE; GUIDELINES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; QUALITY OF LIFE; SUPERIOR VENA CAVA SYNDROME; TERMINALLY ILL;

EID: 0030949257     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(96)00326-0     Document Type: Article

References (26)

1. Heber D, Byerly LO, Chlebowski RT. Metabolic abnormalities in the cancer patient. Cancer 1985; 55:225-229.
2. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-1057.
3. American Diabetes Association, Centre for Economic Studies in Medicine. Direct and indirect costs of diabetes in the United States in 1987. Alexandria, VA: American Diabetes Association, 1988.
4. Wilson JD, Isselbacher KJ, Braunwald E, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine, 12th ed. New York: McGraw Hill, 1991.
5. Holroyde CP, Gabuzda TG, Putnam RC, Paul P. Altered glucose metabolism in metastatic carcinoma. Cancer Res 1975;35:3710-3714.
6. Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 1979;39:1968-1972.
7. Lundholm K, Edström S, Karlberg I, Ekman L, Scherstén T. Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer 1982;50:1142-1150.
8. Tayek JA. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Coll Nutr 1992;11:445-456.
9. Glicksman AS, Rawson RW. Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 1956;9:1127-1134.
10. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripherial glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest 1988;37:15-21.
11. Russell DMR, Shike M, Marliss EB, et al. Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancer. Cancer Res 1984;44:1706-1711.
12. Benn JJ, Ria R, Sonksen PH. Increased glucose carbon recycling in severely insulin deficient type I diabetic subjects. Diabetologia 1990;33:158-162.
13. Butler PC, Kryshad J, Schwenk WF, Haymond MW, Rizza RA. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Diabetes 1990;39:217-225.
14. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990;322:223-228.
15. Axelrod L, Halter JB, Cooper DS, Aoki TT, Roussel AM, Bagshaw SL. Hormonal levels and fuel flow in patients with weight loss and lung cancer. Evidence for excessive metabolic expenditure and for and adaptive response mediated by a reduced level of 3,5,3'-triiodothyronine. Metabolism 1983; 32:924-937.
16. Brennan MF. Total parenteral nutrition in the cancer patient. N Engl J Med 1981;305:375-382.
17. Heber D, Chlebowski RT, Ishibashi DE, Herrold JN, Block JB. Abnormalities in glucose and protein metabolism in non-cachectic lung cancer patients. Cancer Res 1982;42:4815-4819.
18. Jasani B, Donaldson LJ, Ratcliffe JG, Sokhi GS. Mechanism of impaired glucose tolerance in patients with neoplasia. Br J Cancer 1978;38:287-292.
19. Kokal WA, McCulloch A, Wright PD, Johnston IDA. Glucose turnover and recycling in colorectal carcinoma. Ann Surg 1983;198:601-604.
20. Tayek JA, Bulcavage L, Chlebowski RT. Relationship of hepatic glucose production to growth hormone and severity of malnutrition in a population with colorectal carcinoma. Cancer Res 1990;50: 2119-2122.
21. Shaw JHF, Humberstone DM, Wolfe RR. Energy and protein metabolism in sarcoma patients. Ann Surg 1988;207:283-289.
22. Tayek JA, Heber D, Byerley LO, Steiner BS, Rajfer J, Swerdloff RS. Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism 1990;39:1-6.
23. Bennegard K, Eden E, Ekman L, Schersten T, Lundholm K. Metabolic balance across the leg in weight-losing cancer patients compared to depleted patients without cancer. Cancer Res 1982;42:4293-4299.
24. Emerman JT, Leahy M, Gout PW, Bruchovsky N. Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 1985;17: 421-424.
25. Pavelik K, Pekic B, Gravilovac J, Bratic-Mikes V, Boranic M. Hormonal changes in patients with hematological malignancies. Biomedicine 1981;35: 181-184.
26. Benjamin F. Growth hormone response to insulin hypoglycemia in endometrial carcinoma. Obstet Gynecol 1974;43:257-261.